About
Samplimy Medical AB develops painless, self-administered devices for microsampling of blood and interstitial fluid from the skin to enable scalable biomarker detection and diagnostics outside traditional clinical settings.
Explore Samplimy Medical AB's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.